Vaxart's market cap is currently $166.06M. The company's EPS TTM is $-0.408; its P/E ratio is ―; Vaxart is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.38M	$ 107.00K	$ 892.00K	$ 4.05M	$ 9.86M
Gross Profit	$ -60.76M	$ -3.16M	$ -47.86M	$ -15.82M	$ -4.68M
Operating Income	$ -83.35M	$ -114.59M	$ -72.75M	$ -30.17M	$ -15.79M
EBITDA	$ -72.13M	$ -103.12M	$ -66.45M	$ -28.26M	$ -12.17M
Net Income	$ -82.47M	$ -107.76M	$ -70.47M	$ -32.22M	$ -18.64M
Balance Sheet
Cash & Short-Term Investments	$ 39.71M	$ 93.72M	$ 166.49M	$ 126.87M	$ 13.53M
Total Assets	$ 91.83M	$ 153.85M	$ 221.17M	$ 152.58M	$ 37.03M
Total Debt	$ 26.51M	$ 21.70M	$ 13.01M	$ 7.21M	$ 2.31M
Net Debt	$ -8.24M	$ -22.31M	$ -130.74M	$ -119.66M	$ -11.21M
Total Liabilities	$ 34.02M	$ 43.25M	$ 33.64M	$ 29.18M	$ 24.08M
Stockholders' Equity	$ 57.80M	$ 110.60M	$ 187.53M	$ 123.40M	$ 12.95M
Cash Flow
Free Cash Flow	$ -72.32M	$ -104.38M	$ -64.99M	$ -24.97M	$ -13.94M
Operating Cash Flow	$ -70.45M	$ -94.78M	$ -59.83M	$ -23.75M	$ -13.09M
Investing Cash Flow	$ 43.95M	$ -20.41M	$ -49.10M	$ -1.22M	$ -850.00K
Financing Cash Flow	$ 15.24M	$ 17.46M	$ 125.80M	$ 138.31M	$ 15.96M

Currency in USD

Vaxart Earnings and Revenue History

Income Statement >

Vaxart Debt to Assets

Balance Sheet >

Vaxart Cash Flow

Cash Flow >

Vaxart Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing